His laboratory focuses on the contributions of noncoding regions of the genome on ASD risk. He earned his Ph.D. in neuroscience at the Pennsylvania State University. Dr. Campbell was a postdoctoral fellow in the laboratory of Dr. Pat Levitt at Vanderbilt University, where he discovered a functional variant in the MET gene that is associated with ASD risk.